Last reviewed · How we verify
Placebo of D930
This drug is a placebo, meaning it has no active therapeutic effect.
This drug is a placebo, meaning it has no active therapeutic effect. Used for Treatment of symptoms associated with a clinical trial.
At a glance
| Generic name | Placebo of D930 |
|---|---|
| Sponsor | Chong Kun Dang Pharmaceutical |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, it does not interact with any biological molecules or systems, and its effects are purely psychological or due to the natural course of the disease.
Approved indications
- Treatment of symptoms associated with a clinical trial
Common side effects
- No adverse events expected
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of D930 CI brief — competitive landscape report
- Placebo of D930 updates RSS · CI watch RSS
- Chong Kun Dang Pharmaceutical portfolio CI